Nausea and Anxiety Management

Introduction

• Nausea and anxiety management is crucial for patients, with various treatment options available, including pharmacological and non-pharmacological approaches 1, 2

Dosing and Administration

• Benzodiazepines, such as lorazepam, are recommended at a dose of 0.5-2 mg orally, sublingually, or intravenously every 6 hours as needed, by the American College of Physicians and the National Comprehensive Cancer Network 3, 4, 5
• Prochlorperazine can be used at a dose of 10 mg orally every 6 hours as needed for persistent nausea, as recommended by the National Comprehensive Cancer Network 1, 6
• Metoclopramide can be used at a dose of 10-20 mg orally every 4-6 hours for persistent nausea, according to the National Comprehensive Cancer Network 5
• Haloperidol can be used at a dose of 0.5-2 mg orally every 4-6 hours for persistent nausea, as recommended by the National Comprehensive Cancer Network 5
• Olanzapine can be used at a dose of 5-10 mg orally daily, according to the National Comprehensive Cancer Network 5
• Ondansetron can be used at a dose of 4-8 mg orally as needed for nausea management 7
• Buspirone can be initiated at a dose of 5 mg twice daily, titrated gradually to an effective dose, with a maximum dose of up to 20 mg three times daily, as recommended by the American Academy of Family Physicians 8

Benefits and Efficacy

• Benzodiazepines, such as lorazepam, are the most effective pharmacological treatment for anxiety-induced nausea, as recommended by the National Comprehensive Cancer Network 1, 5
• Behavioral therapies, such as progressive muscle relaxation training, systematic desensitization, hypnosis, guided imagery, and cognitive behavioral therapy, have shown high efficacy for treating anxiety-related nausea, as reported by the Annals of Oncology 2
• The World Journal of Emergency Surgery reports that lorazepam helps manage anticipatory nausea and targets dopaminergic pathways effectively for nausea control 4
• The Journal of Clinical Oncology reports that lorazepam is shown superior to metoclopramide in controlling breakthrough nausea and vomiting 9

Special Considerations

• Elderly patients are especially sensitive to benzodiazepine effects, and the lowest effective dose should be used for the shortest duration, as recommended by the National Comprehensive Cancer Network 10
• The British Medical Journal recommends starting with lower doses of lorazepam (0.25-0.5 mg) and a maximum 2 mg in 24 hours for elderly or debilitated patients 3
• The World Journal of Emergency Surgery suggests considering combination therapy with lorazepam plus haloperidol for severe cases 3
• The National Comprehensive Cancer Network recommends considering adding a second agent when first-line medications fail to control symptoms 4
• Anticipatory nausea can become conditioned, making prevention critical, as reported by the Annals of Oncology 2
• Overlooking underlying causes, focusing only on nausea, and ignoring non-pharmacological approaches can lead to treatment failure, as highlighted by the Annals of Oncology 2

Treatment Approach

• The initial assessment should determine the severity of anxiety and nausea, and rule out other causes of nausea, such as gastritis or medication side effects 1
• For mild anxiety-induced nausea, treatment should start with a benzodiazepine, such as lorazepam 0.5 mg orally every 6 hours as needed, and implement behavioral techniques, such as progressive muscle relaxation and deep breathing 1
• For moderate anxiety-induced nausea, the benzodiazepine dose can be increased, and prochlorperazine 10 mg orally every 6 hours can be added if needed 1
• For severe anxiety-induced nausea, benzodiazepine dosing should be optimized, and ondansetron 4-8 mg orally can be added as needed, with consideration of psychiatric referral for specialized anxiety management 1
• The American Academy of Family Physicians recommends monitoring anxiety symptoms using standardized scales, assessing nausea frequency and severity, and evaluating for improvement in panic attack symptoms, with initial follow-up at 2 weeks and subsequent follow-up every 4 weeks until symptoms stabilize 8

Non-Pharmacological Approaches

• Behavioral therapies have shown high efficacy for treating anxiety-related nausea, as reported by the Annals of Oncology 2